Telbermin

DB12639InvestigationalProtein Based Therapies

Telbermin has been used in trials studying the treatment of Foot Ulcer, Foot Ulcer, Diabetic, and Amyotrophic Lateral Sclerosis.

Also known as
reVEG-F · rh-VEGF · rhVEGF
Code names
SNN0029 · VEGF165

Resolves to

Compound
UNII22G76ZW50XCAS205887-54-3
Targets
P17948FLT1

What you can answer from here — as of November 22, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Telbermin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In